Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Isis and AstraZeneca establish antisense target validation program

Jan. 17, 2000

Ares-Serono and Alkermes to collaborate on sustained-release formulations of proteins

Jan. 14, 2000

Lexicon Genetics and Scripps Institute announce functional genomics agreement

Jan. 14, 2000

Alexion signs transgenic agreement with Genzyme Transgenics

Jan. 14, 2000

Abgenix and Elan enter antibody collaboration for neurological diseases

Jan. 13, 2000

AstraZeneca enters agreement with Vion/EPTTCO for cancer drug delivery technology

Jan. 12, 2000

Strategic alliance formed between Medarex and Kirin Brewery

Jan. 12, 2000

OSI Pharmaceuticals licenses gene transcription patent estate to R.W. Johnson

Jan. 12, 2000

Organon signs exclusive agreement with CIMA

Jan. 11, 2000

Abbott and NeuroSearch enter nervous system disorder collaboration

Jan. 11, 2000

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...